Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis
Launched by MASSACHUSETTS GENERAL HOSPITAL · Nov 25, 2019
Trial Information
Current as of May 08, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subjects of ages between 18 and 65 years.
- • 2. Subjects with any Fitzpatrick skin type.
- • 3. Subjects who are proficient in the English language.
- • 4. Willingness to participate in the study.
- • 5. Willingness to undergo experimental procedure.
- • 6. Informed consent agreement signed by the subject.
- • 7. Willingness to follow the follow-up schedule.
- • 8. Willingness not to use any other hyperhidrosis treatment to the tests sites during the study period (i.e. deodorant, at-home iontophoresis, Botox, MiraDry).
- • 9. Patient rates symptoms at level "3" or "4" on the hyperhidrosis disease severity scale (HDSS, see below).
- • 10. Subject in appropriate physical health to ride a stationary bicycle to the point of eliciting sweat.
- • 11. No known allergy to iodine or potato starch
- Exclusion Criteria:
- • 1. Pregnancy
- • 2. Subjects on systemic treatment for hyperhidrosis, such as anticholinergic drugs (e.g. glycopyrrolate), sedatives or tranquilizers, within the past 8 weeks.
- • 3. Subjects who have undergone surgical excision of sweat glands or sympathectomy for hyperhidrosis.
- • 4. Subjects with an underlying disorder, such as neurologic injury or disease affecting the autonomic system, vascular disorders and metabolic disorders (e.g. hyperthyroidism, diabetes mellitus) that can produce hyperhidrosis
- • 5. Subjects with a history of coronary artery disease.
- • 6. Subjects with a history of poor compliance or psychosis
- • 7. Subjects taking SSRIs, SNRIs, TCAs, or MAOIs
- • 8. Subjects with known hypersensitivity to methylene blue
- • 9. Subjects with cardiac pacemaker or any other electrically powered implantable device.
- • 10. Subjects not proficient in the English language.
- • 11. Subject not in appropriate physical health to ride a stationary bicycle to the point of eliciting sweat.
- • 12. Known allergy to iodine or potato starch.
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
R Rox Anderson, MD
Principal Investigator
Massachusetts General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials